Health Canada proposes to limit its own powers under a 2014 consumer drug safety bill. The department held private meetings with pharmaceutical lobbyists before concluding the law passed by Parliament poses a “burden” to industry: “That law could have sent pharmaceutical executives to jail; instead, Health Canada cut a deal.”